Cancer Letters · 2022 · 23 citations · 37 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyTumor MicroenvironmentCombination ChemotherapyPancreatic CancerStromal Cell InteractionsTargeted Cancer TherapyTumor Microenvironment ModulationTumor-stroma InteractionsDual Drug SynergyPancreatic Cancer PharmacotherapyTargeted Agent CombinationsTargeted Combination ChemotherapyTargeted Therapy Pharmacology
37
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations
Medicine, Oncology, Pharmacotherapy +16